Dr. Daniel Vile, DO (he/him) is a Cardiologist, Interventional Cardiologist, Internist in Philadelphia, PA with over 18 years of experience. What is your opinion of Dr. Daniel Vile, DO? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Daniel Vile, DO has received over $6,062 which includes payments from the following companies:
$1,190.77 from BIOTRONIK INC.
$715.69 from Boston Scientific Corporation
$704.79 from AstraZeneca Pharmaceuticals LP
$638.47 from Toshiba America Medical Systems, Inc.
$411.66 from Novartis Pharmaceuticals Corporation
$389.88 from Amgen Inc.
$364.83 from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$304.47 from Janssen Pharmaceuticals, Inc
$244.56 from Abbott Laboratories
$227.52 from E.R. Squibb & Sons, L.L.C.
$217.34 from Daiichi Sankyo Inc.
$174.01 from Medtronic Vascular, Inc.
$108.81 from LILLY USA, LLC
$97.41 from Amarin Pharma Inc.
$88.44 from Boehringer Ingelheim Pharmaceuticals, Inc.
$81.83 from ABIOMED
$43.65 from Pfizer Inc.
$21.60 from Lantheus Medical Imaging, Inc.
$13.86 from Regeneron Healthcare Solutions, Inc.
$12.41 from Philips Electronics North America Corporation
Payments received by Dr. Daniel Vile, DO were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!